Gilead Sciences Inc (GILD)

NASDAQ HEALTHCARE
$128.84 -0.32% RSI 38 Neutral Add Alert

Moving Averages

SMA 200
$124.40
Price above

Company Profile

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.

Sector
HEALTHCARE
Industry
DRUG MANUFACTURERS - GENERAL
Market Cap
$176.36B
P/E Ratio
20.96
EPS
$6.78
Beta
0.404
Dividend Yield
2.23%
52-Week High
$156.4
52-Week Low
$90.95

Similar stocks in DRUG MANUFACTURERS - GENERAL

LLY
Lilly(Eli) & Company
RSI 33.0
PFE
Pfizer Inc
RSI 39.0
JNJ
Johnson & Johnson
RSI 38.0
BMY
Bristol-Myers Squibb Company
RSI 44.0
MRK
Merck & Co Inc
RSI 38.0
NVO
Novo Nordisk
RSI 56.0

Data last updated: April 10, 2026 at 8:18 PM EDT

Track GILD for free

Get e-mail RSI alerts when Gilead Sciences Inc enters oversold or overbought territory. Free forever.

Add Alert